LabGenomics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sung Chin

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

Market Still Lacking Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650)

Apr 09

If You Like EPS Growth Then Check Out LabGenomics (KOSDAQ:084650) Before It's Too Late

Mar 31

CEO

Sung Chin (55 yo)

no data

Tenure

Mr. Sung Hyun Chin served as the Chief Executive Officer of LabGenomics Co., Ltd. Sung Hyun Chin worked at Research Center of Medipost Co., Ltd. Sung Hyun Chin graduated from Chung-Ang University, majored...

LabGenomics Management

Management criteria checks 0/4

Key information

Recent management updates

No independent directors

No independent directors

Recent updates

Market Still Lacking Some Conviction On LabGenomics Co., Ltd. (KOSDAQ:084650)

New major risk - Revenue and earnings growth

Investor sentiment improves as stock rises 21%

Third quarter 2023 earnings released: ₩21.00 loss per share (vs ₩232 profit in 3Q 2022)

Investor sentiment deteriorates as stock falls 16%

Now 23% undervalued

Investor sentiment improves as stock rises 21%

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 24%

Full year 2022 earnings released: EPS: ₩1,429 (vs ₩2,481 in FY 2021)

Investor sentiment deteriorates as stock falls 16%

LabGenomics Co., Ltd. announced that it has received KRW 22.71198072 billion in funding

Upcoming dividend of ₩100.00 per share

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

If You Like EPS Growth Then Check Out LabGenomics (KOSDAQ:084650) Before It's Too Late

New 90-day low: ₩15,300

New 90-day low: ₩15,850

New 90-day low: ₩17,500

New 90-day low: ₩20,600

New 90-day low: ₩27,300

New 90-day low: ₩31,650

New 90-day high - ₩39,250

CEO

Tenure